← Leaderboards
Joseph A Dunn
Omnipharm Research International Inc.
$1,760,508
Attributed
$1,760,508
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,760,508 · 6
By mechanism
R44$1,335,997 · 2
R43$424,511 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionTopical Drug ApplicationLaboratory MouseAntiinflammatory AgentsSkin AbsorptionPhenylamideAntibacterial AgentsSkin PharmacologySkin Disorder ChemotherapySalicylateChemical SynthesisLaboratory RatAcneTransdermal Drug DeliveryAlkyl GroupTissue /Cell CultureProstaglandin Endoperoxide SynthaseChemical Structure FunctionDrug Adverse EffectInflammationDisease /Disorder ModelHydropathyDiabetes MellitusDecubitus Ulcer
Grant awards (8)
New Salicylanildes to Treat Oral Diseases$454,525
R44 · FY2005 · DE
New Salicylanildes to Treat Oral Diseases$131,851
R44 · FY2004 · DE
5-Naphthoylsalicylanilides as improved anti-acne agents$125,001
R43 · FY2004 · AR
Topical Salicylanilides to Treat Diabetic Foot Ulcer$100,000
R43 · FY2002 · DK
Novel Inhibitors of Chemical Absorption Through Skin$99,510
R43 · FY2002 · AR
NEW DRUGS FOR THE TREATMENT OF ACNE, REVISED PLAN$426,901
R44 · FY2001 · AR
NEW DRUGS FOR THE TREATMENT OF ACNE, REVISED PLAN$322,720
R44 · FY2000 · AR
INHIBITION OF UV INDUCED SKIN CANCER BY TRIFLUOROSAL$100,000
R43 · FY2000 · CA